These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

336 related articles for article (PubMed ID: 25408270)

  • 1. The vulnerable myocardium. Diabetic cardiomyopathy.
    Bugger H; Bode C
    Hamostaseologie; 2015; 35(1):17-24. PubMed ID: 25408270
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The vulnerable myocardium.
    Bugger H; Bode C
    Hamostaseologie; 2015; 35(1):17-24. PubMed ID: 29589349
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diabetic cardiomyopathy: An expression of stage B heart failure with preserved ejection fraction.
    Lam CS
    Diab Vasc Dis Res; 2015 Jul; 12(4):234-8. PubMed ID: 25908570
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Emerging role of epigenetics and miRNA in diabetic cardiomyopathy.
    Asrih M; Steffens S
    Cardiovasc Pathol; 2013; 22(2):117-25. PubMed ID: 22951386
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diabetic cardiomyopathy: mechanisms and new treatment strategies targeting antioxidant signaling pathways.
    Huynh K; Bernardo BC; McMullen JR; Ritchie RH
    Pharmacol Ther; 2014 Jun; 142(3):375-415. PubMed ID: 24462787
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low-dose copper infusion into the coronary circulation induces acute heart failure in diabetic rats: New mechanism of heart disease.
    Cheung CC; Soon CY; Chuang CL; Phillips AR; Zhang S; Cooper GJ
    Biochem Pharmacol; 2015 Sep; 97(1):62-76. PubMed ID: 26208785
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Can We Prevent Mitochondrial Dysfunction and Diabetic Cardiomyopathy in Type 1 Diabetes Mellitus? Pathophysiology and Treatment Options.
    Cieluch A; Uruska A; Zozulinska-Ziolkiewicz D
    Int J Mol Sci; 2020 Apr; 21(8):. PubMed ID: 32325880
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diabetic cardiomyopathy revisited.
    Boudina S; Abel ED
    Circulation; 2007 Jun; 115(25):3213-23. PubMed ID: 17592090
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exercise Amaliorates Metabolic Disturbances and Oxidative Stress in Diabetic Cardiomyopathy: Possible Underlying Mechanisms.
    Mahmoud AM
    Adv Exp Med Biol; 2017; 999():207-230. PubMed ID: 29022265
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A new insight of mechanisms, diagnosis and treatment of diabetic cardiomyopathy.
    Zhang X; Chen C
    Endocrine; 2012 Jun; 41(3):398-409. PubMed ID: 22322947
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term severe diabetes only leads to mild cardiac diastolic dysfunction in Zucker diabetic fatty rats.
    Daniels A; Linz D; van Bilsen M; Rütten H; Sadowski T; Ruf S; Juretschke HP; Neumann-Haefelin C; Munts C; van der Vusse GJ; van Nieuwenhoven FA
    Eur J Heart Fail; 2012 Feb; 14(2):193-201. PubMed ID: 22253456
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Diabetic cardiomyopathy].
    Huang YQ; Wang X; Kong W
    Sheng Li Ke Xue Jin Zhan; 2010 Feb; 41(1):31-6. PubMed ID: 21417012
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chronic administration of the nitroxyl donor 1-nitrosocyclo hexyl acetate limits left ventricular diastolic dysfunction in a mouse model of diabetes mellitus in vivo.
    Cao N; Wong YG; Rosli S; Kiriazis H; Huynh K; Qin C; Du XJ; Kemp-Harper BK; Ritchie RH
    Circ Heart Fail; 2015 May; 8(3):572-81. PubMed ID: 25737497
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MiR-21 protected against diabetic cardiomyopathy induced diastolic dysfunction by targeting gelsolin.
    Dai B; Li H; Fan J; Zhao Y; Yin Z; Nie X; Wang DW; Chen C
    Cardiovasc Diabetol; 2018 Sep; 17(1):123. PubMed ID: 30180843
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oxidative stress: a key contributor to diabetic cardiomyopathy.
    Khullar M; Al-Shudiefat AA; Ludke A; Binepal G; Singal PK
    Can J Physiol Pharmacol; 2010 Mar; 88(3):233-40. PubMed ID: 20393588
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vascular endothelial dysfunction, a major mediator in diabetic cardiomyopathy.
    Knapp M; Tu X; Wu R
    Acta Pharmacol Sin; 2019 Jan; 40(1):1-8. PubMed ID: 29867137
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An overview of the crosstalk between inflammatory processes and metabolic dysregulation during diabetic cardiomyopathy.
    Palomer X; Salvadó L; Barroso E; Vázquez-Carrera M
    Int J Cardiol; 2013 Oct; 168(4):3160-72. PubMed ID: 23932046
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diabetic cardiomyopathy and diastolic heart failure -- difficulties with relaxation.
    Teupe C; Rosak C
    Diabetes Res Clin Pract; 2012 Aug; 97(2):185-94. PubMed ID: 22502812
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Taxifolin prevents diabetic cardiomyopathy in vivo and in vitro by inhibition of oxidative stress and cell apoptosis.
    Sun X; Chen RC; Yang ZH; Sun GB; Wang M; Ma XJ; Yang LJ; Sun XB
    Food Chem Toxicol; 2014 Jan; 63():221-32. PubMed ID: 24269735
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diabetic cardiomyopathy: understanding the molecular and cellular basis to progress in diagnosis and treatment.
    Falcão-Pires I; Leite-Moreira AF
    Heart Fail Rev; 2012 May; 17(3):325-44. PubMed ID: 21626163
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.